IgA Nephropathy (IgAN), also known as Berger’s disease, is a kidney disorder characterized by the deposition of immunoglobulin A (IgA) antibodies in the glomeruli of the kidneys, leading to inflammation and damage. As the most common primary glomerulonephritis worldwide, IgAN poses significant challenges in healthcare management. Understanding its market dynamics, epidemiology, and pipeline activities isContinue reading “IgA Nephropathy Market Insights, Epidemiology, and Market Forecast – 2032”